Slides 15-18 describe meningococcal disease, its incidence and notification in the United Kingdom.
In slides 19-25 Professor Cartwright looks at the current strategy for meningococcal disease in the UK in the short and medium term, the emphasis being on minimizing morbidity and mortality by rapid recognition and treatment and on disease elimination by vaccine development. Slide 20 illustrates the glass test, a well documented means of determining if a rash is blanching or non-blanching.
